Lifecore Biomedical, Inc. Common Stock

Day range

$6.40 – $6.44

Open

$6.41

Prev close

$6.40

Volume

336.69K

Market cap

$242.6M

Shares out

37.85M

P/E

—

P/S

1.85

P/B

181.58

P/FCF

—

ROE

-3840.6%

ROA

-21.4%

Debt/Equity

95.06

Div yield

0.00%

As of Oct 23, 2026

• Merger agreementOct 20, 2026

  As previously disclosed, on September 27, 2026, Lifecore Biomedical, Inc. (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") with Lifecore Inc. and Hazel Merger Sub, Inc.

• Significant contract awardSep 29, 2026

  Pursuant to the Third Amendment, the parties agreed to extend the term of the Contract Manufacturing Agreement ... to an Initial Term ending December 31, 2034. The parties also amended an exhibit to establish Alcon's minimum purchase obligations through 2034.

• Credit facilitySep 28, 2026

  Parent has obtained commitments for debt financing from two third party lenders for an aggregate of $115 million in term loans and an aggregate of $30 million in a revolving credit facility, and from Alcon for $35 million in a term loan.

• Investor presentationAug 5, 2026

  On August 5, 2026, the Company made available on its website certain investor presentation materials (the "Investor Presentation"). A copy of the Investor Presentation is furnished as Exhibit 99.2 to this Current Report on Form 8-K.

• Capital allocation updateJul 2, 2026

  The Company has previously begun and continues to evaluate a range of strategic alternatives to facilitate the redemptions, including use of cash on hand, potential debt or equity financing transactions, and/or other possible strategic transactions, and to seek the requisite consents from the Company's lenders. The Company intends to seek alternatives that it believes will improve its capital structure for what it expects to be its next phase of growth.

Days to cover

4.1

Short interest

2.48M

Avg volume

605.56K

As of Sep 30, 2026 · reported to FINRA twice monthly.

• Halper Sadeh LLC is Investigating Whether MG, LFCR, MGLD are Obtaining Fair Deals for their Shareholders
  negativeGlobeNewswire Inc.· Oct 4, 2026
• Pomerantz LLP and The Rosen Law Firm, P.A. Announce Proposed Class Action Settlement on Behalf of Purchasers of Lifecore Biomedical, Inc. Securities - LFCR
  negativeGlobeNewswire Inc.· Apr 6, 2026
• Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company
  positiveGlobeNewswire Inc.· Mar 23, 2026
• Green Dot Corporation Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
  negativeGlobeNewswire Inc.· Mar 16, 2026
• Lifecore Biomedical Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
  negativeGlobeNewswire Inc.· Mar 16, 2026